Whittier Trust CO Of Nevada Inc Novartis Ag Transaction History

Whittier Trust CO Of Nevada Inc

  • $4.02 Billion
  • Q4 2024

A detailed history of Whittier Trust CO Of Nevada Inc transactions in Novartis Ag stock. As of the latest transaction made, Whittier Trust CO Of Nevada Inc holds 24,072 shares of NVS stock, worth $2.7 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
24,072
Previous 22,851 5.34%
Holding current value
$2.7 Million
Previous $2.63 Million 10.88%
% of portfolio
0.06%
Previous 0.07%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
BUY
$96.78 - $117.18 $118,168 - $143,076
1,221 Added 5.34%
24,072 $2.34 Million
Q3 2024

Oct 21, 2024
SELL
$106.13 - $120.89 $221,705 - $252,539
-2,089 Reduced 8.38%
22,851 $2.63 Million
Q2 2024

Jul 26, 2024
SELL
$92.57 - $107.37 $65,909 - $76,447
-712 Reduced 2.78%
24,940 $2.66 Million
Q1 2024

May 02, 2024
SELL
$95.27 - $108.47 $49,064 - $55,862
-515 Reduced 1.97%
25,652 $2.48 Million
Q4 2023

Jan 11, 2024
BUY
$92.27 - $101.54 $115,060 - $126,620
1,247 Added 5.0%
26,167 $2.64 Million
Q3 2023

Oct 27, 2023
SELL
$94.73 - $105.13 $12,883 - $14,297
-136 Reduced 0.54%
24,920 $2.54 Million
Q2 2023

Jul 24, 2023
SELL
$92.52 - $104.91 $22,574 - $25,598
-244 Reduced 0.96%
25,056 $2.53 Million
Q1 2023

Apr 21, 2023
SELL
$80.03 - $92.81 $255,535 - $296,342
-3,193 Reduced 11.21%
25,300 $2.33 Million
Q4 2022

Jan 25, 2023
SELL
$75.55 - $92.52 $62,857 - $76,976
-832 Reduced 2.84%
28,493 $0
Q3 2022

Oct 21, 2022
SELL
$74.61 - $87.26 $43,646 - $51,047
-585 Reduced 1.96%
29,325 $2.23 Million
Q2 2022

Jul 28, 2022
SELL
$80.52 - $93.75 $62,886 - $73,218
-781 Reduced 2.54%
29,910 $2.53 Million
Q4 2021

Jan 19, 2022
SELL
$79.7 - $88.13 $171,275 - $189,391
-2,149 Reduced 6.54%
30,691 $2.69 Million
Q3 2021

Nov 01, 2021
BUY
$81.78 - $95.14 $12,512 - $14,556
153 Added 0.47%
32,840 $2.69 Million
Q2 2021

Jul 29, 2021
SELL
$85.24 - $94.15 $102,714 - $113,450
-1,205 Reduced 3.56%
32,687 $2.98 Million
Q1 2021

Apr 26, 2021
SELL
$83.5 - $98.47 $31,730 - $37,418
-380 Reduced 1.11%
33,892 $2.9 Million
Q4 2020

Jan 29, 2021
SELL
$78.07 - $94.43 $65,344 - $79,037
-837 Reduced 2.38%
34,272 $3.24 Million
Q3 2020

Oct 30, 2020
SELL
$82.14 - $91.0 $90,682 - $100,464
-1,104 Reduced 3.05%
35,109 $3.05 Million
Q2 2020

Jul 10, 2020
SELL
$80.93 - $91.1 $45,806 - $51,562
-566 Reduced 1.54%
36,213 $3.16 Million
Q1 2020

Apr 27, 2020
SELL
$70.67 - $99.01 $59,150 - $82,871
-837 Reduced 2.23%
36,779 $3.03 Million
Q4 2019

Jan 31, 2020
BUY
$84.35 - $95.37 $92,531 - $104,620
1,097 Added 3.0%
37,616 $3.56 Million
Q3 2019

Oct 18, 2019
BUY
$85.54 - $94.26 $51,324 - $56,556
600 Added 1.67%
36,519 $3.17 Million
Q2 2019

Jul 23, 2019
SELL
$75.4 - $92.8 $234,343 - $288,422
-3,108 Reduced 7.96%
35,919 $3.28 Million
Q1 2019

Apr 29, 2019
SELL
$75.32 - $86.15 $41,877 - $47,899
-556 Reduced 1.4%
39,027 $3.75 Million
Q4 2018

Feb 07, 2019
SELL
$73.66 - $82.02 $40,733 - $45,357
-553 Reduced 1.38%
39,583 $3.4 Million
Q3 2018

Oct 23, 2018
SELL
$66.94 - $77.43 $92,109 - $106,543
-1,376 Reduced 3.31%
40,136 $3.46 Million
Q2 2018

Jul 27, 2018
SELL
$64.91 - $73.36 $426,523 - $482,048
-6,571 Reduced 13.67%
41,512 $3.14 Million
Q2 2018

Jul 20, 2018
BUY
$64.91 - $73.36 $397,638 - $449,403
6,126 Added 14.6%
48,083 $4.35 Million
Q1 2018

May 01, 2018
SELL
$70.39 - $84.15 $6,968 - $8,330
-99 Reduced 0.24%
41,957 $3.39 Million
Q4 2017

Feb 07, 2018
SELL
$72.33 - $77.64 $81,660 - $87,655
-1,129 Reduced 2.61%
42,056 $3.53 Million
Q3 2017

Oct 23, 2017
BUY
$74.14 - $77.27 $3.2 Million - $3.34 Million
43,185
43,185 $3.71 Million

Others Institutions Holding NVS

# of Institutions
1,478
Shares Held
134M
Call Options Held
1.31M
Put Options Held
1.56M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $241B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Whittier Trust CO Of Nevada Inc Portfolio

Follow Whittier Trust CO Of Nevada Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO Of Nevada Inc, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO Of Nevada Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email